# Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

> **NCT00136032** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 63 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Somatropin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00136032
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2008-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136032, "Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00136032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*